INTRODUCTION {#sec1}
============

Ureteral stents are deployed to overcome intrinsic or extrinsic causes of upper urinary tract obstruction, thus aiding the drainage of urine from kidneys to the bladder \[[@cit0001], [@cit0002]\]. They are often related to the treatment of kidney stone disease (KSD) and with a rising incidence and a lifetime prevalence of KSD at 14%, the use of stents is going to increase further \[[@cit0003]\]. Since their first use, stents have been prone to mechanical, physico-chemical and biological failures, such as encrustation and biofilm formation \[[@cit0005], [@cit0006]\].

An ideal stent would offer simple insertion and removal without discomfort, would not result in migration upon deployment, and would resist biofilm formation or encrustations. A stent with these characteristics would not compromise a patient\'s quality of life ([Figure 1](#f0001){ref-type="fig"}). While a number of changes have taken place regarding the size and the length of a stent, in this mini-review we will outline the engineering developments relating to stent material, design and surface coating ([Figure 2](#f0002){ref-type="fig"}).

![Characteristics of an ideal stent.](CEJU-70-1520-g001){#f0001}

![Factors affecting stent technology.](CEJU-70-1520-g002){#f0002}

MATERIAL AND METHODS {#sec2}
====================

To engineer an ideal ureteric stent, developments are required on three key technology areas: the constitutive material of the stent, its surface properties, and the stent architecture ([Figure 2](#f0002){ref-type="fig"}). In the following sections, we will provide an overview of recent innovations in these areas.

Stent material {#sec2.1}
--------------

There are three main classes of materials that are employed to fabricate ureteric stents: metals, polymers and bio-degradable/bio-absorbable materials \[[@cit0007]--[@cit0014]\] ([Table 1](#t0001){ref-type="table"}). Polymeric stents are more favored due to their biologically inert properties in comparison to metal stents. They typically comprise of thermoplastic, thermoset elastomers and other proprietary materials, which are mostly silicone-based \[[@cit0001], [@cit0002], [@cit0003]\]. Bio- degradable/bio-absorbable stents are more recent, and have been shown to reduce the requirement for secondary procedures (i.e. stent removal). The time taken for the stent to be absorbed depends on the material type and potential surface coatings \[[@cit0004]\]. Dual durometer stents consist of a material that transitions from hard proximally to soft distally, with the purpose of decreasing bladder irritation \[[@cit0005]\].

###### 

Summary of the most commonly used materials for ureteral stents to date

                              Innovations in material                                                                                                                   Key comments by manufacturer or reported in a scientific publication                                              Commercial example
  --------------------------- ----------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------
  Polymeric                   Silicone                                                                                                                                  Highly biocompatible when compared to other materials \[[@cit0002]\]                                              FLUORO-4™ (Bard^®^, USA)
  Polyurethane                High drainage performance and High epithelial erosion \[[@cit0002], [@cit0010]\]                                                          Bardex^®^ (Bard^®^, USA)                                                                                          
  Silitek™                    High tensile strength, weak coil retention, high incident rate of edema \[[@cit0011]\]                                                    (Medical Engineering^©^, Argentina)                                                                               
  Percuflex™                  Cost effective, efficient urine drainage and coil retention, low coil and tensile strength \[[@cit0001]\]                                 (Boston^®^ Scientific, USA)                                                                                       
  C-Flex^®^                   Lower surface friction allowing less particle adhesion, lower mechanical strength compared to polyurethane and PureFlex™ \[[@cit0001]\]   (Cook^©^ Medical, USA)                                                                                            
  Dual Durometer              Minimizes bladder irritation \[[@cit0008]\]                                                                                               (Bioteq^©^, Taiwan)                                                                                               
  Metal                       MP35N alloy, a composite of non- magnetic nickel-cobalt- chromium-molybdenum                                                              Metallic double pigtail stent that possesses a high tensile strength and resistance to corrosion \[[@cit0007]\]   Resonance^®^ Metallic ureteral stent (Cook Medical, Bloomington, IN, USA)
  Nickel Titanium (Nitinol)   Soft and strong, not indicated for patients with functional stenosis or stone formation \[[@cit0007]\]                                    Memokath 051 ureteral stent (PNN^©^ medical, Denmark)                                                             
  Stainless steel             Simplicity of fabrication, removal may be complex \[[@cit0005], [@cit0007]\]                                                              Wall stent (Boston^®^ Scientific, USA)                                                                            
  Biodegradable               Reduction of secondary procedures \[[@cit0004], [@cit0009]\]                                                                              Uriprene (Poly-Med Inc., USA)                                                                                     

Metallic stents were first introduced by Gort et al., and gained popularity due to their resistance against deformation caused by extrinsic/intrinsic strictures \[[@cit0006], [@cit0007], [@cit0008]\].

[Table 1](#t0001){ref-type="table"} summarizes the commonly used materials for ureteral stents, as well as a few commercial examples \[[@cit0001], [@cit0002], [@cit0004], [@cit0006], [@cit0008]--[@cit0012]\].

Stent coating {#sec2.2}
-------------

Coatings are evolutions in ureteric stents that allow a decrease in friction, resulting in easier stent passage over a guidewire \[[@cit0013]\]. Moreover, they can potentially help reducing formation of biofilms and encrustations \[[@cit0006]\]. Coatings have also the potential for reducing inflammation caused by the release of ions from metal stents \[[@cit0003]\]. Specific coatings may also be employed for drug eluting purposes \[[@cit0014]\].

Notably, reduced surface adhesion and friction from coatings has been associated with increased stent lifetime and has improved the patient\'s quality of life. [Table 2](#t0002){ref-type="table"} summarizes the stent coatings that are commonly used or have been researched \[[@cit0015]--[@cit0026]\].

###### 

Summary of the most commonly used coatings for ureteral stents to date

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Innovations in material      Key comments by manufacturer or reported in a scientific publication                                                                                                                                      Commercial example or method of reported study
  ---------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------
  Heparin (a blood thinner)    Prevention of biofilm and encrustation \[[@cit0020]\]                                                                                                                                                     In-vivo human patient

  Polyvinylpyrrolidone (PVP)   Provides a non-adhesive surface due to its lubricant properties and water-solubility \[[@cit0014]\]                                                                                                       In-vitro study

  Antibiotic                   Bacterial uropathogens growth prevention, antimicrobial properties, drug elution \[[@cit0019]\]                                                                                                           In-vivo study on rat model

  Carbon (diamond- like)       Decreasing biofilm formation and encrustation \[[@cit0015]\]                                                                                                                                              In-vivo study human patient

  Hyaluronic acid              Prevention of growth and nucleation of salts, decreasing protein surface assimilation \[[@cit0022]\]                                                                                                      In-vitro study on rat model

  Triclosan                    Uropathogens and bacterial growth prevention, FDA concern on the potential for causing bacterial resistance \[[@cit0018]\]                                                                                In-vivo studies e.g. Triumph™ (Boston^®^ Scientific, USA)

  Silver                       In comparison to ordinary stent, silver-coated stents appear to perform better in preventing biofilm formation; however, prolonged usage of these coatings can potentially cause argyria \[[@cit0023]\]   In-vitro study 'plant infection model'

  Gendine                      Biofilm and ureteric infection prevention \[[@cit0023]\]                                                                                                                                                  In-vivo study on rabbit

  Chitosan                     Biofilm prevention, especially a derivation with polymethylmethacrylate (PMMA) \[[@cit0016], [@cit0025]\]                                                                                                 In-vitro study

  Salicylic acid               Salicylic acid release, due to the hydrolysation of the salicyl acrylate polymer coating in aqueous environment, prevents biofilm formation \[[@cit0017], [@cit0024]\]                                    In-vitro study

  Hydrogel                     High water solubility properties provide a thin layer of water that potentially prevents the creation of conditioning film and biofilm\                                                                   In-vitro (in human urine) study
                               However, there are variable results regarding the level of effectiveness of this coating \[[@cit0021]\]                                                                                                   
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Stent design {#sec2.3}
------------

Stent design, on the other hand, is one of the areas that have experienced many scientific trials and associated modifications globally \[[@cit0010], [@cit0027]\]. While stent design changes have allowed the double-J structure as a default for almost all stents, its main rationale was to avoid migration of these stents once placed successfully.

Similar stent modifications have also happened with regard to the stent drainage, such as side holes along with other novelties such as spiral stents, mesh stents, stents with variations in tail designs and the method of removal of these stents. A future research area relates to the fluidic aspects of stent drainage, which may become more important with in-vitro research data suggesting that it can govern encrustation and biofilm formation \[[@cit0028]\]. [Table 3](#t0003){ref-type="table"} summarizes the various designs and provides examples of their representing stents on the market \[[@cit0009]--[@cit0036]\].

###### 

Summary of most commonly used designs for ureteral stents to date

  Innovations in design   Key comments by manufacturer or reported in a scientific publication                                                                                                                                                                                                   Commercial example or method of reported study
  ----------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------
  Double-J                Decreasing migration of stent both proximally and distally. This design is employed in most of the ureteral stents currently on the market \[[@cit0028]\]                                                                                                              In-vivo human patient
  Double-J 3D             Believed to provide a better proximal and distal retention                                                                                                                                                                                                             Silicon Figure Four (SFF) (Bard^®^, USA)
  Loop                    Believed to provide a 69% volume reduction in the amount of material inside bladder, and better patient comfort                                                                                                                                                        Polaris™ Loop ureteral stent (Boston^®^ Scientific, USA)
  Mesh                    Less frequency of upper urinary tract inflammation, but more difficult to place compared to standard unmeshed ureteral stents \[[@cit0034]\]                                                                                                                           In-vivo study on pig model
  Expandable              This design is believed to provide a higher intra-luminal flow, and ease of insertion and retrieval                                                                                                                                                                    Allium^®^ Ureteral Stent (Allium Medical Solutions^®^, Israel)
  Magnetic- tip           Allowing more effective retrieval due to the presence of magnetic material (stainless steel bead) at the distal end of the stent                                                                                                                                       Magnetic Black- Star (Urovision, Germany)
  String                  The extraction string is designed to be attached to the stent to facilitate removal \[[@cit0035]\]                                                                                                                                                                     In-vivo human patient study
  Coil- Reinforced        It allows efficient drainage because of the larger lumen, it reduces kinking and buckling, and has high compressive resistance \[[@cit0036]\]                                                                                                                          Silhouette^®^ stent (Applied Medical, USA)
  Basket                  Its ability to widen laterally upon an activation force improves passageway for small stones and stops bigger stones' migration through ureter                                                                                                                         Ureteral Stone Sweeper^®^ (Fossa^®^ Medical, USA)
  Spiral Cut              This type includes having the standard solid lumen of the ureteral stent at the distal and proximal region and spiral cut lumen through the rest of the stent. The stent is claimed to result in fewer upper tract symptoms \[[@cit0030]\]                             In-vivo pig model study
  Linearly Expandable     A design in which the stent has got spiral wire spring sandwiched between inner and outer lining of the stent wall to maintain urine flow in the presence of an obstruction \[[@cit0032]\]                                                                             In-vitro study
  Helical                 Side holes that emerge from the main body of the stent, direct the flow into the lumen thanks to the hole projecting out of the stent lumen and therefore potentially results in potrntially better drainage of the urine and passage of small stones \[[@cit0033]\]   In-silico study
  Grooved                 Specifically designed for patients treated with lithotripsy, enabling stone fragments to travel efficiently along the ureter \[[@cit0029], [@cit0031]\]                                                                                                                Towers Peripheral Ureteral Stent (Cook^®^ Medical, USA)

CONCLUSIONS {#sec3}
===========

Stents have evolved over the last century with a wide variety of available materials, coatings and designs. An ideal stent still remains a panacea, but potential solutions would lie in further engineering evolutions in an era of widespread and increasing clinical use of ureteric stents.
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